| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |